Breakthrough Epigenetic Editing Enables Durable Gene Silencing in Human T Cells Without DNA Damage
Researchers have demonstrated a new epigenetic editing approach that provides durable gene silencing in primary human T cells without causing DNA damage. The technology, called CRISPRoff, maintains gene repression through multiple cell divisions and shows minimal cellular toxicity compared to traditional CRISPR-Cas9 methods. This breakthrough could significantly advance cell therapy development and genetic research applications.
Revolutionary Epigenetic Editing Platform
Scientists have developed a groundbreaking epigenetic editing technology that can permanently silence genes in human immune cells without altering the underlying DNA sequence, according to research published in Nature Biotechnology. The approach, reportedly called CRISPRoff, enables durable gene repression that persists through approximately 30-80 cell divisions, representing a significant advancement over previous temporary gene silencing methods.
